1. Home
  2. IDN vs PMVP Comparison

IDN vs PMVP Comparison

Compare IDN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

N/A

Current Price

$2.82

Market Cap

73.5M

Sector

Technology

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.23

Market Cap

66.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDN
PMVP
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
66.1M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
IDN
PMVP
Price
$2.82
$1.23
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
463.7K
290.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.06
N/A
Revenue
$4,433,454.00
N/A
Revenue This Year
$12.54
N/A
Revenue Next Year
$15.32
N/A
P/E Ratio
$47.33
N/A
Revenue Growth
23.21
N/A
52 Week Low
$2.70
$1.02
52 Week High
$9.08
$1.88

Technical Indicators

Market Signals
Indicator
IDN
PMVP
Relative Strength Index (RSI) 27.47 49.82
Support Level $2.70 $1.04
Resistance Level $4.49 $1.26
Average True Range (ATR) 0.16 0.06
MACD -0.03 0.00
Stochastic Oscillator 11.40 26.67

Price Performance

Historical Comparison
IDN
PMVP

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: